Bwell First Aid Antibiotic
NDC Package 69006-012-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Bwell First Aid Antibiotic is a . Marketed by Viaderma Ii, Inc, this product is identified by NDC 69006-012 and is authorized under FDA application M004.

Identification & Billing

NDC Package Code
69006-012-01
Package Description
1 BOTTLE in 1 BOX / 55 mL in 1 BOTTLE
Product Code
69006-012
11-Digit Billing Format
69006001201

Clinical Specifications

Proprietary Name
Bwell First Aid Antibiotic
Dosage Form
-

Regulatory & Marketing

Labeler Name
Viaderma Ii, Inc
FDA Application #
M004
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
05-01-2020
End Marketing Date
12-18-2024
Listing Expiration
12-18-2024
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69006-012-01 identifies a specific commercial package of 1 bottle in 1 box / 55 ml in 1 bottle of Bwell First Aid Antibiotic, labeled by Viaderma Ii, Inc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Viaderma Ii, Inc on May 01, 2020. The current certification is valid through December 18, 2024.

How is this Viaderma Ii, Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69006001201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
69006-012-01
11-Digit CMS (5-4-2)
69006-0012-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.